Sanjeev Wadhwani

Head of Rx, EMEAC @ Galderma

About

20+ years of global commercial experience in launching innovative therapies and devices in orphan diseases and specialty conditions. Demonstrated capability to build and lead high performing teams, manage P&L and OpEx targets, build strong brands and lifecycle management strategy, and enable access to innovative therapies. Results-oriented, energetic, intellectually curious, with a strong track-record in linking strategy to execution. Fueled by team energy. High strategic agility and results driven. Board experience. Previous roles include General Manager, Head of Marketing & Commercial Excellence, Global Commercial Lead, New Products & Franchise Innovation Leader, Board of Directors/Research Chair, Management Consultant / Business Development. Therapeutic Area Experience: Immunology, Hematology, Oncology, Rare Metabolic Diseases, Internal Medicine, Neuroscience, Ophthalmology

Country

City

Switzerland

Industry

Pharmaceuticals

Skill

Financial Reporting, Launches, Mergers & Acquisitions (M&A), Teamwork, Sales, Launch Experience, Market Access, Communication, Commercialization, Strategy, Global Marketing, P&L Management, Biotechnology, Pharmaceutical Industry, Life Sciences, Product Management, Product Launch, Drug Development, Competitive Analysis, Market Analysis

Experience

Head of Rx, EMEAC

Galderma

2023-10 - Present · 3 yrs

Switzerland

Drive Therapeutic Dermatology (TD) Inline/OTC Performance across Europe, Middle East, Africa, Canada (exceeding top & bottom line targets YoY) Transform EMEAC Organization towards Biologics Launch Readiness Lead, Coach, and Grow a Winning Team

Managing Director & Co-Founder

PxCentric L.L.C.

2020-2 - Present · 6 yrs 8 mos

PxCentric L.L.C. is a international healthcare consultancy supporting clients in achieving greater results through elevating the voice of key stakeholders, particularly involving patient and prescriber excellence. Key Engagements: Head of MENA Cluster (Medison Pharma) Global Advocacy Organization Upskilling Biotech Startup Build Rare Disease Operating Model Commercial Field Force Strategy & Planning Patient Services Strategy Pre-launch Commercialization Competitor Assessment

Chair, Board Of Directors, Research Chair

Sickle Cell Awareness Group of Ontario (SCAGO)

2020-11 - 2026 · 5 yrs

Toronto, Ontario, Canada

Vice President, GM Middle East & Head of Marketing & Commercial Excellence (Europe & Middle East)

Global Blood Therapeutics

2020-9 - 2023-3 · 2 yrs 7 mos

Switzerland

Full P&L responsibility for GBT's Middle East region Build and lead Europe/ Middle East Marketing & Commercial Excellence functions Executive Leadership Team Member, TRIAD Lead, Region/ Country Pricing Governance accountabilities GBT is now a subsidiary of Pfizer as of October 2022